Related references
Note: Only part of the references are listed.Inactive disease in patients with lupus is linked to autoantibodies to type I interferons that normalize blood IFNa and B cell subsets
Hannah F. Bradford et al.
CELL REPORTS MEDICINE (2023)
Emerging principles of cytokine pharmacology and therapeutics
Robert A. Saxton et al.
NATURE REVIEWS DRUG DISCOVERY (2023)
Temporal Dynamics of Anti-Type 1 Interferon Autoantibodies in Patients With Coronavirus Disease 2019
Elana R. Shaw et al.
CLINICAL INFECTIOUS DISEASES (2022)
Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection
Jonas Schuhenn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
Jeremy Manry et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-α
Alexis Mathian et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
Distinct Type I Interferon Subtypes Differentially Stimulate T Cell Responses in HIV-1-Infected Individuals
Zehra Karakoese et al.
FRONTIERS IN IMMUNOLOGY (2022)
IFNα subtype-specific susceptibility of HBV in the course of chronic infection
Xiaohong Xie et al.
FRONTIERS IN IMMUNOLOGY (2022)
Functional Comparison of Interferon-α Subtypes Reveals Potent Hepatitis B Virus Suppression by a Concerted Action of Interferon-α and Interferon-γ Signaling
Jieliang Chen et al.
HEPATOLOGY (2021)
Shared and Unique Features of Human Interferon-Beta and Interferon-Alpha Subtypes
Megen C. Wittling et al.
FRONTIERS IN IMMUNOLOGY (2021)
Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine
Paul Bastard et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Differential levels of IFNα subtypes in autoimmunity and viral infection
Vincent Bondet et al.
CYTOKINE (2021)
Viral infections in humans and mice with genetic deficiencies of the type I IFN response pathway
Isabelle Meyts et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2021)
Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy
Elise M. N. Ferre et al.
FRONTIERS IN PEDIATRICS (2021)
Autoantibodies neutralizing type I IFNs are present in ∼4% of uninfected individuals over 70 years old and account for ∼20% of COVID-19 deaths
Paul Bastard et al.
SCIENCE IMMUNOLOGY (2021)
IFN-alpha kinoid in systemic lupus erythematosus: results from a phase IIb, randomised, placebo-controlled study
Frederic A. Houssiau et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Diversity of locally produced IFN-α subtypes in human nasopharyngeal epithelial cells and mouse lung tissues during influenza virus infection
Lei Yang et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2020)
Human Type I Interferon Antiviral Effects in Respiratory and Reemerging Viral Infections
Patricio L. Acosta et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2020)
Characterization of Type-I IFN subtype autoantibodies and activity in SLE serum and urine
Bethany D. Harris et al.
LUPUS (2020)
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
Qian Zhang et al.
SCIENCE (2020)
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Paul Bastard et al.
SCIENCE (2020)
Qualitative Differences Between the IFNα subtypes and IFNβ Influence Chronic Mucosal HIV-1 Pathogenesis
Kejun Guo et al.
PLOS PATHOGENS (2020)
The Role of Structure in the Biology of Interferon Signaling
Mark R. Walter
FRONTIERS IN IMMUNOLOGY (2020)
A molecular switch from STAT2-IRF9 to ISGF3 underlies interferon-induced gene transcription
Ekaterini Platanitis et al.
NATURE COMMUNICATIONS (2019)
Antiviral potential of human IFN-α subtypes against influenza A H3N2 infection in human lung explants reveals subtype-specific activities
Aline da Rocha Matos et al.
EMERGING MICROBES & INFECTIONS (2019)
Detection of interferon alpha protein reveals differential levels and cellular sources in disease
Mathieu P. Rodero et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Expression Pattern of Individual IFNA Subtypes in Chronic HIV Infection
Yanpeng Li et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2017)
The Significance of Type-I Interferons in the Pathogenesis and Therapy of Human Immunodeficiency Virus 1 Infection
Bowen Wang et al.
FRONTIERS IN IMMUNOLOGY (2017)
AIRE-Deficient Patients Harbor Unique High-Affinity Disease-Ameliorating Autoantibodies
Steffen Meyer et al.
CELL (2016)
Type I interferon-mediated monogenic autoinflammation: The type I interferonopathies, a conceptual overview
Mathieu P. Rodero et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Interferon Alpha Subtype-Specific Suppression of HIV-1 Infection In Vivo
Kerry J. Lavender et al.
JOURNAL OF VIROLOGY (2016)
Distinct Functions of Autoantibodies Against Interferon in Systemic Lupus Erythematosus A Comprehensive Analysis of Anticytokine Autoantibodies in Common Rheumatic Diseases
Sarthak Gupta et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Virus Multiplicity of Infection Affects Type I Interferon Subtype Induction Profiles and Interferon-Stimulated Genes
Luna A. Zaritsky et al.
JOURNAL OF VIROLOGY (2015)
Interferon-α Subtypes in an Ex Vivo Model of Acute HIV-1 Infection: Expression, Potency and Effector Mechanisms
Michael S. Harper et al.
PLOS PATHOGENS (2015)
A new transcriptional role for matrix metalloproteinase-12 in antiviral immunity
David J. Marchant et al.
NATURE MEDICINE (2014)
Myxovirus Resistance Gene A (MxA) Expression Suppresses Influenza A Virus Replication in Alpha Interferon-Treated Primate Cells
Shannon R. Matzinger et al.
JOURNAL OF VIROLOGY (2013)
Blockade of Chronic Type I Interferon Signaling to Control Persistent LCMV Infection
Elizabeth B. Wilson et al.
SCIENCE (2013)
Persistent LCMV Infection Is Controlled by Blockade of Type I Interferon Signaling
John R. Teijaro et al.
SCIENCE (2013)
Structural Linkage between Ligand Discrimination and Receptor Activation by Type I Interferons
Christoph Thomas et al.
CELL (2011)
Binding and activity of all human alpha interferon subtypes
Thomas B. Lavoie et al.
CYTOKINE (2011)
Evolutionary genetic dissection of human interferons
Jeremy Manry et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines
Kai Kisand et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
The role of differential expression of human interferon-A genes in antiviral immunity
Pierre Genin et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2009)
Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I
E. S. Husebye et al.
JOURNAL OF INTERNAL MEDICINE (2009)
Enhanced anti-HCV activity of interferon alpha 17 subtype
Aurelie Dubois et al.
VIROLOGY JOURNAL (2009)
Severe systemic lupus erythematosus induced by antiviral treatment for hepatitis C
Vincent Ho et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2008)
The Stability of the Ternary Interferon-Receptor Complex Rather than the Affinity to the Individual Subunits Dictates Differential Biological Activities
Eyal Kalie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Rigid Interferon-α Subtype Responses of Human Plasmacytoid Dendritic Cells
Richard Szubin et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2008)
Origin and physiological roles of inflammation
Ruslan Medzhitov
NATURE (2008)
JAK-STAT signaling: From interferons to cytokines
Christian Schindler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
CD4+ T-cell death induced by infectious and noninfectious HIV-1:: role of type 1 interferon-dependent, TRAEL/DR5-mediated apoptosis
JP Herbeuval et al.
BLOOD (2005)
Interferons, interferon-like cytokines, and their receptors
S Pestka et al.
IMMUNOLOGICAL REVIEWS (2004)
Differential expression of IFN-α subtypes in human PBMC:: evaluation of novel real-time PCR assays
S Löseke et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2003)